Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Linda M. Kampschreur"'
Autor:
Linda M. Kampschreur, Marjolijn C.A. Wegdam-Blans, Peter C. Wever, Nicole H.M. Renders, Corine E. Delsing, Tom Sprong, Marjo E.E. van Kasteren, Henk Bijlmer, Daan Notermans, Jan Jelrik Oosterheert, Frans S. Stals, Marrigje H. Nabuurs-Franssen, Chantal P. Bleeker-Rovers
Publikováno v:
Emerging Infectious Diseases, Vol 21, Iss 7, Pp 1183-1188 (2015)
Chronic Q fever, caused by Coxiella burnetii, has high mortality and morbidity rates if left untreated. Controversy about the diagnosis of this complex disease has emerged recently. We applied the guideline from the Dutch Q Fever Consensus Group and
Externí odkaz:
https://doaj.org/article/71f6abf9b05d46f38efb1ded89e60439
Autor:
Linda M. Kampschreur, Elske Hoornenborg, Nicole H. M. Renders, Jan Jelrik Oosterheert, Joost F. Haverman, Peter Elsman, Peter C. Wever
Publikováno v:
Emerging Infectious Diseases, Vol 19, Iss 5, Pp 768-773 (2013)
Untreated chronic Q fever causes a high number of complications and deaths. We present cases of chronic Q fever that were not diagnosed until after the patients underwent cardiac valve surgery. In epidemic areas, Q fever screening of valve surgery pa
Externí odkaz:
https://doaj.org/article/b1446c11215242e1aedc5d4592ae72e0
Autor:
Linda M. Kampschreur, Sandra Dekker, Julia C.J.P. Hagenaars, Peter J. Lestrade, Nicole H.M. Renders, Monique G.L. de Jager-Leclercq, Mirjam H.A. Hermans, Cornelis A.R. Groot, Rolf H.H. Groenwold, Andy I.M. Hoepelman, Peter C. Wever, Jan Jelrik Oosterheert
Publikováno v:
Emerging Infectious Diseases, Vol 18, Iss 4, Pp 563-570 (2012)
Since 2007, the Netherlands has experienced a large Q fever outbreak. To identify and quantify risk factors for development of chronic Q fever after Coxiella burnetii infection, we performed a case–control study. Comorbidity, cardiovascular risk fa
Externí odkaz:
https://doaj.org/article/9f205da12f6d4c9fa7367bda2ed11656
Autor:
Abraham Rutgers, Peter E Westerweel, Bronno van der Holt, Simone Postma, Marit G A van Vonderen, Djura P Piersma, Douwe Postma, Maarten van den Berge, Eefje Jong, Marten de Vries, Leonie van der Burg, Dennis Huugen, Marjolein van der Poel, Linda M Kampschreur, Marcel Nijland, Jaap H Strijbos, Menno Tamminga, Pim G N J Mutsaers, Suzanne Schol-Gelok, Margriet Dijkstra-Tiekstra, Grigory Sidorenkov, Julien Vincenten, Wouter H van Geffen, Marjolein Knoester, Jos Kosterink, Reinold Gans, Coen Stegeman, Gerwin Huls, Tom van Meerten
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0271807 (2022)
IntroductionThe aim of this study was to determine the efficacy of early tocilizumab treatment for hospitalized patients with COVID-19 disease.MethodsOpen-label randomized phase II clinical trial investigating tocilizumab in patients with proven COVI
Externí odkaz:
https://doaj.org/article/3bf7a127854345ea86ed69eefc55604e
Autor:
Rosalinde A L Smits, Stella Trompet, Carolien M J van der Linden, Jessica M van der Bol, Steffy W M Jansen, Harmke A Polinder-Bos, Hanna C Willems, Dennis G Barten, Laura C Blomaard, Mark G J de Boer, Floor J A van Deudekom, Jacobien L J Ellerbroek, Jan Festen, Esther M M van de Glind, Linda M Kampschreur, Ouafae Karimi, Bart Kroon, Marc G J A van Lanen, Jacinta A Lucke, Huub A A M Maas, Francesco U S Mattace-Raso, Barbara C van Munster, Lisette Reijerse, Sarah H M Robben, Rikje Ruiter, Henrike J Schouten, Petra E Spies, Anna Wassenburg, Marjolein A Wijngaarden, Simon P Mooijaart
Publikováno v:
Age and Ageing, 51(3). OXFORD UNIV PRESS
Age and ageing, 51(3):afac048. Oxford University Press
Age and Ageing, 51(3):afac048. Oxford University Press
Age and ageing, 51(3):afac048. Oxford University Press
Age and Ageing, 51(3):afac048. Oxford University Press
Background as the coronavirus disease of 2019 (COVID-19) pandemic progressed diagnostics and treatment changed. Objective to investigate differences in characteristics, disease presentation and outcomes of older hospitalised COVID-19 patients between
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5c12d37e6776b7812a56e0552ee51da
http://hdl.handle.net/1887/3303605
http://hdl.handle.net/1887/3303605
Autor:
Roy Looman, Harmke A Polinder-Bos, Marielle H. Emmelot-Vonk, Esther M.M. van de Glind, Esther J. M. de Brouwer, Huub A.A.M. Maas, Jeannet C Bos, Ralph Vreeswijk, Barbara C. van Munster, Laura C. Blomaard, Linda M Kampschreur, Jessica M. van der Bol, Steffy W. Jansen, Liesbeth Hempenius, Hanna C. Willems, Marjolein A. Wijngaarden, Anke J Borgers, Jan Festen, Petra E. Spies, Dennis G Barten, Aisha M Salarbaks, Rosalinde A L Smits, Ad M Kamper, Cees van Nieuwkoop, Sarah H M Robben, Marlies E M Regtuijt, Geert Labots, Frederiek van den Bos, Raya E S Geels, Carolien M. J. van der Linden, Francesco U.S. Mattace-Raso, Henrike J. Schouten, Marre M M de Koning, Bas de Groot, Leanne B L E Oosterwijk, Simon P. Mooijaart, Jacinta A. Lucke, Caroline E. Wyers, Rikje Ruiter, Rachida el Moussaoui, Oscar J. de Vries, Suzanne C. van Dijk, Floor J. van Deudekom, Orla M Smit
Publikováno v:
Age and Ageing
Age and Ageing, 50(3), 631-640. Oxford University Press
Age and ageing, 50(3), 631-640. Oxford University Press
Age and Ageing, 50(3), 631-640. Oxford UP
Age and Ageing, 50(3), 631-640. Oxford University Press
Age and ageing, 50(3), 631-640. Oxford University Press
Age and Ageing, 50(3), 631-640. Oxford UP
Background During the first wave of the coronavirus disease 2019 (COVID-19) pandemic, older patients had an increased risk of hospitalisation and death. Reports on the association of frailty with poor outcome have been conflicting. Objective The aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4321a40d9167d6bef00eb1569f6447c4
https://pubmed.ncbi.nlm.nih.gov/33951156
https://pubmed.ncbi.nlm.nih.gov/33951156
Autor:
P. Gruteke, Jan Jelrik Oosterheert, S E van Roeden, Chantal P. Bleeker-Rovers, Peter C. Wever, Andy I.M. Hoepelman, Linda M. Kampschreur, W. van der Hoek
Publikováno v:
Clinical Microbiology and Infection, 25, 1390-1398
Clinical Microbiology and Infection, 25(11), 1390. Elsevier Limited
Clinical Microbiology and Infection, 25, 11, pp. 1390-1398
Clinical Microbiology and Infection, 25(11), 1390. Elsevier Limited
Clinical Microbiology and Infection, 25, 11, pp. 1390-1398
Objectives Chronic infection with Coxiella burnetii (chronic Q fever) can cause life-threatening conditions such as endocarditis, infected vascular prostheses, and infected arterial aneurysms. We aimed to assess prognosis of chronic Q fever patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b787bea3e338b6ec141d1cf7a080ba8a
http://hdl.handle.net/2066/209649
http://hdl.handle.net/2066/209649
Autor:
Jan Jelrik Oosterheert, Chantal P. Bleeker-Rovers, Peter C. Wever, I M Hoepelman, Daphne F. M. Reukers, C H M van Jaarsveld, Linda M. Kampschreur, S E van Roeden
Publikováno v:
QJM-Monthly Journal of the Association of Physicians, 111(11), 791. Oxford University Press
Quarterly Journal of Medicine, 111, 791-797
Quarterly Journal of Medicine, 111, 11, pp. 791-797
Quarterly Journal of Medicine, 111, 791-797
Quarterly Journal of Medicine, 111, 11, pp. 791-797
Item does not contain fulltext Background: Chronic Q fever is accompanied by high mortality and morbidity, and requires prolonged antibiotic treatment. Little is known on long-term quality of life (LQOL) in chronic Q fever patients treated with antib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81f44b11a080b5a116618699b446321b
https://doi.org/10.1093/qjmed/hcy171
https://doi.org/10.1093/qjmed/hcy171
Autor:
Ilse J E, Kouijzer, Linda M, Kampschreur, Peter C, Wever, Corneline, Hoekstra, Marjo E E, van Kasteren, Monique G L, de Jager-Leclercq, Marrigje H, Nabuurs-Franssen, Marjolijn C A, Wegdam-Blans, Heidi S M, Ammerlaan, Jacqueline, Buijs, Lioe-Fee de, Geus-Oei, Wim J G, Oyen, Chantal P, Bleeker-Rovers
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 59(1)
In 1%-5% of all acute Q fever infections, chronic Q fever develops, mostly manifesting as endocarditis, infected aneurysms, or infected vascular prostheses. In this study, we investigated the diagnostic value of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a1c5b1d5cc9ac38e0def56efc1a6b367
https://pubmed.ncbi.nlm.nih.gov/28546336
https://pubmed.ncbi.nlm.nih.gov/28546336
Autor:
Marrigje H. Nabuurs-Franssen, Cornelis A. R. Groot, Monique G.L. de Jager-Leclercq, Chantal P. Bleeker-Rovers, Jan Jelrik Oosterheert, Marjo E. E. Van Kasteren, Yvonne E. P. Soethoudt, Tom Sprong, Corine E Delsing, Peter C. Wever, Marjolijn C.A. Wegdam-Blans, Sybrandus N. Blank, Andy I. M. Hoepelman, Marjolijn J. H. Pronk, Rolf H.H. Groenwold, Annemarie M. C. Koop, Linda M. Kampschreur, Nicole H. M. Renders
Publikováno v:
Clinical and Vaccine Immunology, 19, 787-90
Clinical and Vaccine Immunology, 19, 5, pp. 787-90
Clinical and Vaccine Immunology, 19, 5, pp. 787-90
Diagnosis of chronic Q fever is difficult. PCR and culture lack sensitivity; hence, diagnosis relies mainly on serologic tests using an immunofluorescence assay (IFA). Optimal phase I IgG cutoff titers are debated but are estimated to be between 1:80
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::969056a4057f5c5a937a0105a81e0f1e
https://hdl.handle.net/2066/108667
https://hdl.handle.net/2066/108667